Jianhua Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianhua Li has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Cunmin Zhang
Yunnan Institute for Drug Abuse, Yunnan, China
1 shared publication- Hongjie Liu
Department of Epidemiology and Biostatistics, School of Public Health, University of Maryland , College Park, Maryland
1 shared publication - Hongjie Liu
Department of Epidemiology and Community Health, Virginia Commonwealth University, Richmond, Virginia, USA
1 shared publication J. Luo
Yunnan Institute for Drug Abuse, Kunming, Yunnan, China
1 shared publication- Toan Ha
Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States
1 shared publication Xinyue Li
National Methadone Maintenance Treatment Training Centre, Yunnan Institute for Drug Abuse, Kunming, Yunnan, China
1 shared publication
Latest Publications
- 1 September 2015
- Published by Elsevier in Public Health
- Vol. 129 (9) , 1237-1243
Disassortative mixing patterns of drug-using and sex networks on HIV risk behaviour among young drug users in Yunnan, China
- 1 September 2015
- Published by Elsevier in Public Health
- Vol. 129 (9) , 1237-1243
Disassortative mixing patterns of drug-using and sex networks on HIV risk behaviour among young drug users in Yunnan, China
- 1 December 2013
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 21 (4) , S37-S41
Current status of drug use and HIV/AIDS prevention in drug users in China
The objective of this paper is to review the current status of drug use and HIV/AIDS prevention for drug users in China and provide scientific evidence for HIV/AIDS prevention and control in drug users. Literature and articles related to drug abuse in China, as well as the results of prevention efforts and successful cases regarding HIV/AIDS prevention in drug users, are reviewed. Lessons learned are drawn out for the future improvement of work and the sustainable development of treatment programs. The number of drug users in China is increasing. Even though the number of opioid-type drug users is growing more slowly than in the past, the number of amphetamine-type stimulant users has increased sharply. It has been proven that methadone maintenance treatment and syringe exchange programs gradually and successfully control HIV/AIDS transmission in drug users. However, it is necessary to enhance these prevention methods and expand their coverage. In addition, the strengthening of antiretroviral therapy (ART) treatment for HIV-infected drug users is crucial for HIV/AIDS prevention and control. The rapidly growing number of amphetamine-type stimulant users, along with their high-risk behavior, poses a hidden danger of greater HIV/AIDS transmission through sexual intercourse in the near future.
- 1 December 2013
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 21 (4) , S37-S41
Current status of drug use and HIV/AIDS prevention in drug users in China
The objective of this paper is to review the current status of drug use and HIV/AIDS prevention for drug users in China and provide scientific evidence for HIV/AIDS prevention and control in drug users. Literature and articles related to drug abuse in China, as well as the results of prevention efforts and successful cases regarding HIV/AIDS prevention in drug users, are reviewed. Lessons learned are drawn out for the future improvement of work and the sustainable development of treatment programs. The number of drug users in China is increasing. Even though the number of opioid-type drug users is growing more slowly than in the past, the number of amphetamine-type stimulant users has increased sharply. It has been proven that methadone maintenance treatment and syringe exchange programs gradually and successfully control HIV/AIDS transmission in drug users. However, it is necessary to enhance these prevention methods and expand their coverage. In addition, the strengthening of antiretroviral therapy (ART) treatment for HIV-infected drug users is crucial for HIV/AIDS prevention and control. The rapidly growing number of amphetamine-type stimulant users, along with their high-risk behavior, poses a hidden danger of greater HIV/AIDS transmission through sexual intercourse in the near future.
- Open Access
- 1 January 2010
- Published by Springer Nature in Harm Reduction Journal
- Vol. 7 (1) , 4
The Chinese government's response to drug use and HIV/AIDS: A review of policies and programs
Illicit drug use has become popular in China. Acknowledging the challenge of illicit drug use, China has adopted several new policies on the management of illicit drug use in recent years. This study reviews the current policies on drug use and assesses the harm reduction interventions among drug users in China. The review documents that the new policies on drug use provide a variety of choices of detoxification treatment for drug users. The methadone maintenance treatment and needle exchange programs have been adopted as harm reduction models in China. Most of the reviewed harm reduction programs have been successfully implemented and yielded positive effects in reducing drug related risk behaviors among drug users. Although there remain barriers to the effective implementation of policies on drug use and harm reduction programs, Chinese government has shown their commitment to support the expansion of harm reduction interventions for drug users throughout the country.
- 1 January 2010
- Published by Springer Nature in Harm Reduction Journal
- Vol. 7 (1) , 4
Open AccessThe Chinese government's response to drug use and HIV/AIDS: A review of policies and programs
Illicit drug use has become popular in China. Acknowledging the challenge of illicit drug use, China has adopted several new policies on the management of illicit drug use in recent years. This study reviews the current policies on drug use and assesses the harm reduction interventions among drug users in China. The review documents that the new policies on drug use provide a variety of choices of detoxification treatment for drug users. The methadone maintenance treatment and needle exchange programs have been adopted as harm reduction models in China. Most of the reviewed harm reduction programs have been successfully implemented and yielded positive effects in reducing drug related risk behaviors among drug users. Although there remain barriers to the effective implementation of policies on drug use and harm reduction programs, Chinese government has shown their commitment to support the expansion of harm reduction interventions for drug users throughout the country.